Logo image of CBNA

CHAIN BRIDGE BANCORP INC-A (CBNA) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CBNA - US15746L1008 - Common Stock

30.96 USD
-0.38 (-1.21%)
Last: 11/26/2025, 2:48:15 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CBNA. CBNA was compared to 387 industry peers in the Banks industry. The financial health of CBNA is average, but there are quite some concerns on its profitability. CBNA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CBNA had positive earnings in the past year.
CBNA had a positive operating cash flow in the past year.
CBNA Yearly Net Income VS EBIT VS OCF VS FCFCBNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

CBNA has a better Return On Assets (1.21%) than 77.00% of its industry peers.
CBNA's Return On Equity of 11.42% is fine compared to the rest of the industry. CBNA outperforms 78.04% of its industry peers.
Industry RankSector Rank
ROA 1.21%
ROE 11.42%
ROIC N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBNA Yearly ROA, ROE, ROICCBNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 5 10

1.3 Margins

CBNA has a better Profit Margin (35.24%) than 92.25% of its industry peers.
The Operating Margin and Gross Margin are not available for CBNA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 35.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBNA Yearly Profit, Operating, Gross MarginsCBNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

CBNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CBNA has more shares outstanding
CBNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CBNA Yearly Shares OutstandingCBNA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CBNA Yearly Total Debt VS Total AssetsCBNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B

2.2 Solvency

There is no outstanding debt for CBNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC10.01%
CBNA Yearly LT Debt VS Equity VS FCFCBNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 50M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBNA Yearly Current Assets VS Current LiabilitesCBNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 132.05% over the past year.
Looking at the last year, CBNA shows a very strong growth in Revenue. The Revenue has grown by 70.68%.
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.1%
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.36%

3.2 Future

Based on estimates for the next years, CBNA will show a decrease in Earnings Per Share. The EPS will decrease by -8.79% on average per year.
The Revenue is expected to grow by 11.65% on average over the next years. This is quite good.
EPS Next Y-27.57%
EPS Next 2Y0.35%
EPS Next 3Y-8.79%
EPS Next 5YN/A
Revenue Next Year7.39%
Revenue Next 2Y14.46%
Revenue Next 3Y11.65%
Revenue Next 5YN/A

3.3 Evolution

CBNA Yearly Revenue VS EstimatesCBNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 20M 40M 60M
CBNA Yearly EPS VS EstimatesCBNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 1 2 3 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CBNA is valuated reasonably with a Price/Earnings ratio of 10.83.
CBNA's Price/Earnings ratio is a bit cheaper when compared to the industry. CBNA is cheaper than 64.34% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.98, CBNA is valued rather cheaply.
A Price/Forward Earnings ratio of 7.10 indicates a rather cheap valuation of CBNA.
Based on the Price/Forward Earnings ratio, CBNA is valued cheaply inside the industry as 90.18% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.79, CBNA is valued rather cheaply.
Industry RankSector Rank
PE 10.83
Fwd PE 7.1
CBNA Price Earnings VS Forward Price EarningsCBNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CBNA is valued a bit more expensive than 70.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.17
EV/EBITDA N/A
CBNA Per share dataCBNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

CBNA's earnings are expected to decrease with -8.79% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.35%
EPS Next 3Y-8.79%

More info and screens

0

5. Dividend

5.1 Amount

CBNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHAIN BRIDGE BANCORP INC-A

NYSE:CBNA (11/26/2025, 2:48:15 PM)

30.96

-0.38 (-1.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-28 2025-10-28/amc
Earnings (Next)01-26 2026-01-26
Inst Owners47.56%
Inst Owner Change7.55%
Ins Owners24.89%
Ins Owner Change61.9%
Market Cap203.10M
Revenue(TTM)52.87M
Net Income(TTM)18.63M
Analysts80
Price Target34.68 (12.02%)
Short Float %1.48%
Short Ratio3.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.72%
Min EPS beat(2)-2.86%
Max EPS beat(2)30.3%
EPS beat(4)3
Avg EPS beat(4)21.5%
Min EPS beat(4)-2.86%
Max EPS beat(4)53.38%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.87%
Min Revenue beat(2)0.96%
Max Revenue beat(2)6.78%
Revenue beat(4)4
Avg Revenue beat(4)12%
Min Revenue beat(4)0.96%
Max Revenue beat(4)25.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.33%
PT rev (3m)13.33%
EPS NQ rev (1m)1.27%
EPS NQ rev (3m)1.27%
EPS NY rev (1m)0.22%
EPS NY rev (3m)0.22%
Revenue NQ rev (1m)3.12%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)1.16%
Revenue NY rev (3m)-1.03%
Valuation
Industry RankSector Rank
PE 10.83
Fwd PE 7.1
P/S 3.84
P/FCF 19.17
P/OCF 15.02
P/B 1.25
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)2.86
EY9.24%
EPS(NY)4.36
Fwd EY14.08%
FCF(TTM)1.61
FCFY5.22%
OCF(TTM)2.06
OCFY6.66%
SpS8.06
BVpS24.86
TBVpS24.86
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 11.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 35.24%
GM N/A
FCFM 20.03%
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 614.92%
Cap/Sales 5.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 56.85%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC10.01%
ROIC/WACCN/A
Cap/Depr(3y)39.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.53%
Cap/Sales(5y)N/A
Profit Quality(3y)151.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)132.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.1%
EPS Next Y-27.57%
EPS Next 2Y0.35%
EPS Next 3Y-8.79%
EPS Next 5YN/A
Revenue 1Y (TTM)70.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.36%
Revenue Next Year7.39%
Revenue Next 2Y14.46%
Revenue Next 3Y11.65%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.13%
OCF growth 3YN/A
OCF growth 5YN/A

CHAIN BRIDGE BANCORP INC-A / CBNA FAQ

Can you provide the ChartMill fundamental rating for CHAIN BRIDGE BANCORP INC-A?

ChartMill assigns a fundamental rating of 3 / 10 to CBNA.


Can you provide the valuation status for CHAIN BRIDGE BANCORP INC-A?

ChartMill assigns a valuation rating of 4 / 10 to CHAIN BRIDGE BANCORP INC-A (CBNA). This can be considered as Fairly Valued.


How profitable is CHAIN BRIDGE BANCORP INC-A (CBNA) stock?

CHAIN BRIDGE BANCORP INC-A (CBNA) has a profitability rating of 2 / 10.


Can you provide the financial health for CBNA stock?

The financial health rating of CHAIN BRIDGE BANCORP INC-A (CBNA) is 4 / 10.


Can you provide the expected EPS growth for CBNA stock?

The Earnings per Share (EPS) of CHAIN BRIDGE BANCORP INC-A (CBNA) is expected to decline by -27.57% in the next year.